Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PERSEUS - A Prospective Non-interventional Study to Assess the Effectiveness of Aflibercept (Eylea®) in Routine Clinical Practice in Patients With Wet Age-related Macular Degeneration

NCT01914380 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01914380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01914380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PERSEUS - A Prospective Non-interventional Study to Assess the Effectiveness of Aflibercept (Eylea®) in Routine Clinical Practice in Patients With Wet Age-related Macular Degeneration
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
July 29, 2013
Completion date
March 31, 2017
Enrollment
988 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wet age-related macular degeneration